Zymeworks Common Stock Stock Price on June 15, 2024
| ZYME Stock | USD 12.92 0.14 1.07% |
Below is the normalized historical share price chart for Zymeworks Common Stock extending back to April 28, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zymeworks Common stands at 12.92, as last reported on the 11th of December 2024, with the highest price reaching 12.92 and the lowest price hitting 12.92 during the day.
If you're considering investing in Zymeworks Stock, it is important to understand the factors that can impact its price. At this point, Zymeworks Common is not too volatile. Zymeworks Common Stock shows Sharpe Ratio of 0.0447, which attests that the company had a 0.0447% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Zymeworks Common Stock, which you can use to evaluate the volatility of the company. Please check out Zymeworks Common's Market Risk Adjusted Performance of 0.2143, mean deviation of 2.13, and Downside Deviation of 2.82 to validate if the risk estimate we provide is consistent with the expected return of 0.14%.
At present, Zymeworks Common's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 149.4 M, whereas Common Stock is forecasted to decline to about 510.8 M. . As of December 11, 2024, Price To Sales Ratio is expected to decline to 8.94. In addition to that, Price Earnings Ratio is expected to decline to -6.33. Zymeworks Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of April 2017 | 200 Day MA 11.0819 | 50 Day MA 14.0247 | Beta 1.157 |
Zymeworks |
Sharpe Ratio = 0.0447
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ZYME | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.1 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Zymeworks Common is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zymeworks Common by adding it to a well-diversified portfolio.
Price Book 2.6746 | Enterprise Value Ebitda 0.3383 | Price Sales 14.5509 | Shares Float 41.2 M | Wall Street Target Price 17.8556 |
Related Headline
Blueprint Medicines Headline on 14th of June 2024
Acquisition by Coats Lonnel of 4570 shares of Blueprint Medi... by Coats Lonnel
Filed transaction by Blueprint Medicines Corp Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Zymeworks Common Valuation on June 15, 2024
It is possible to determine the worth of Zymeworks Common on a given historical date. On June 15, 2024 Zymeworks was worth 9.08 at the beginning of the trading date compared to the closed value of 9.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zymeworks Common stock. Still, in general, we apply an absolute valuation method to find Zymeworks Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zymeworks Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zymeworks Common's related companies.
| Open | High | Low | Close | Volume | |
| 9.33 | 9.47 | 9.06 | 9.11 | 585,500 | |
06/14/2024 | 9.08 | 9.16 | 8.91 | 9.04 | 591,000 |
| 9.17 | 9.24 | 8.53 | 8.54 | 404,600 |
| Backtest Zymeworks Common | | | Zymeworks Common History | | | Zymeworks Common Valuation | Previous | Next |
Zymeworks Common Trading Date Momentum on June 15, 2024
| On June 17 2024 Zymeworks Common Stock was traded for 8.54 at the closing time. The top price for the day was 9.24 and the lowest listed price was 8.53 . The trading volume for the day was 404.6 K. The trading history from June 17, 2024 was a factor to the next trading day price decrease. The trading date delta against the next closing price was 5.53% . The trading date delta against the current closing price is 6.64% . |
Zymeworks Common Stock Fundamentals Correlations and Trends
By evaluating Zymeworks Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zymeworks Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zymeworks financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zymeworks Common Stock history
Zymeworks Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zymeworks is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zymeworks Common Stock will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zymeworks Common stock prices may prove useful in developing a viable investing in Zymeworks Common
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 68.9 M | 42.3 M | |
| Net Income Applicable To Common Shares | 111.9 M | 117.5 M |
Zymeworks Common Quarterly Net Working Capital |
|
Zymeworks Common Stock Technical Analysis
Zymeworks Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Zymeworks Common Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Zymeworks Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zymeworks Common December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Zymeworks Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zymeworks Common shares will generate the highest return on investment. By undertsting and applying Zymeworks Common stock market strength indicators, traders can identify Zymeworks Common Stock entry and exit signals to maximize returns
Zymeworks Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zymeworks Common's price direction in advance. Along with the technical and fundamental analysis of Zymeworks Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zymeworks to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0578 | |||
| Jensen Alpha | 0.089 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.0312 | |||
| Treynor Ratio | 0.2043 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |